Home / Biotechnology / Preterm Birth And PROM Testing Market By Test Type (Pelvic Exam, Ferning Test, Nitrazine Test, Pooling Test, Ultrasound Test, Uterine Monitoring Test, Biomarkers) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Preterm Birth And PROM Testing Market By Test Type (Pelvic Exam, Ferning Test, Nitrazine Test, Pooling Test, Ultrasound Test, Uterine Monitoring Test, Biomarkers) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Published: Mar 2019 | Report Code: 59644-03-19

Industry Outlook

The preterm birth and PROM testing market is set to reach from US$ 996.3 Mn in 2017 to US$ 1,201.2 Mn by 2026 representing slow growth at a compounded annual growth rate (CAGR) of 2.1% during the forecast period from 2018 to 2026. As per the research findings of World Health Organization (WHO), annually 15 million babies are born before the completion of 37 weeks of normal pregnancy and as a result approximately 1 million children die every year due to complications associated with preterm births.

Market Synopsis

Preterm Birth And PROM Testing Market

Get a sample copy for more information

Excellent diagnostic accuracy and sensitivity will increase the popularity of biomarkers as PROM testing kits

Physicians investigate preliminary symptoms such as vaginal bleeding, vaginal discharge, pelvic pressure etc., to confirm preterm birth complications. Pelvic examination is the first line of diagnostic approach which is performed several times over a period of time to study the contraction and changes of cervix. If the cervix begins to soften, dilate and become thin before 37 weeks of pregnancy the patient is diagnosed with preterm labor. Biomarkers such as Alpha-fetoprotein test (AFT), insulin like growth factor binding protein-1 (IGFBP-1), placental alpha macroglobulin-1 (PAMG-1) etc., are gaining tremendous attention in the last decade. Excellent diagnostic accuracy and sensitivity increases the popularity of biomarkers as PROM testing kits.

Preterm Birth And PROM Testing Market

Get a sample copy for more information

"Rising incidence of premature births and increasing maternal health awareness together drive the market growth in North America region"

In the present scenario North America is leading the regional segment for preterm birth and PROM testing market with a share of 36%. Annually 3.9 million babies are born in North America of which 12.0% are born prematurely. Rising incidence of premature births and increasing maternal health awareness together drive the market growth in North America region. Existence of major players such as Abbott Laboratories, Inc., CooperSurgical, Inc., Qiagen, Inc., Hologic, Inc. etc. further propel the market growth in North America region. Europe is the second largest market with a share of 28% on account of supportive regulatory environment provided by the European Medical Agency (EMA) for PROM testing kits and establishment of well-developed healthcare infrastructure. Asia Pacific currently holds 15% market share and will be showcasing rapid growth in the near future owing to increasing complication related to pregnancy and proactive government initiatives to provide optimum maternal care.

Preterm Birth And PROM Testing Market

Get a sample copy for more information

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The market is segmented by test type and by geography. 

ATTRIBUTE DETAILS
Research Period  2017-2027
Base Year 2018
Forecast Period  2019-2027
Historical Year  2017
Unit  USD Million
Segmentation

 By Test Type (2016–2026; US$ Mn)
 • Pelvic Exam
 • Ferning Test
 • Nitrazine Test
 • Pooling Test
 • Ultrasound Test
 • Uterine Monitoring Test
 • Biomarkers

 Geography Segment (2016–2026; US$ Mn)
 • North America (U.S., Canada)
 • Europe (U.K., Germany, Rest of Europe)
 • Asia Pacific (China, Japan, Rest of APAC)
 • Latin America (Brazil, Mexico, Rest of Latin America)
 • Middle East and Africa (GCC, Rest of the Middle East and Africa)

Biopharmaceutical companies specializing in manufacturing preterm birth and PROM testing kits are Abbott Laboratories, Inc., Biosynex, Clinical Innovations, LLC, CooperSurgical, Inc., Hologic, Inc., IQ Products, Medixbiochemica, NX Prenatal, Inc., Qiagen N.V. and Sera Prognostics, Inc.

Key questions answered in this report

  • What will be the market assessment for preterm birth and prom testing market?
  • What are the major symptoms associated with preterm labor and premature ruptures of membranes?
  • Which major biopharmaceutical companies are actively engaged in the production of PROM testing test?
  • What is the significance of pelvic examination during preterm labor?
  • Which factors are responsible for the popularity of biomarkers as a diagnostic kit during for PROM?
  • What is the current share of North America and its performance in the near future?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Test Types
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Preterm Birth and PROM Testing Market Portraiture
2.2. Global Preterm Birth and PROM Testing Market, by Test Type, 2017 (US$ Mn)
2.3. Global Preterm Birth and PROM Testing Market, by Geography, 2017 (US$ Mn)

Chapter 3. Preterm Birth and PROM Testing Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Preterm Birth and PROM Testing Market, by Key Players, 2017

Chapter 4. Global Preterm Birth and PROM Testing Market, by Test Type
4.1. Overview
4.2. Pelvic Exam
4.3. Ferning Test
4.4. Nitrazine Test
4.5. Pooling Test
4.6. Ultrasound Test
4.7. Uterine Monitoring Test
4.8. Biomarkers

Chapter 5. Global Preterm Birth and PROM Testing Market, by Geography
5.1. Overview
5.2. North America Preterm Birth and PROM Testing Market Analysis, 2016 – 2026
5.2.1. North America Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
5.2.2. North America Preterm Birth and PROM Testing Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Preterm Birth and PROM Testing Market Analysis, 2016 – 2026
5.3.1. Europe Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
5.3.2. Europe Preterm Birth and PROM Testing Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Preterm Birth and PROM Testing Market Analysis, 2016 – 2026
5.4.1. Asia Pacific Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific Preterm Birth and PROM Testing Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America Preterm Birth and PROM Testing Market Analysis, 2016 – 2026
5.5.1. Latin America Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
5.5.2. Latin America Preterm Birth and PROM Testing Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa Preterm Birth and PROM Testing Market Analysis, 2016 – 2026
5.6.1. MEA Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
5.6.2. MEA Preterm Birth and PROM Testing Market, by Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. Biosynex
6.3. Clinical Innovations, LLC
6.4. CooperSurgical, Inc.
6.5. Hologic, Inc.
6.6. IQ Products.
6.7. Medixbiochemica
6.8. NX Prenatal, Inc.
6.9. Qiagen N.V.
6.10. Sera Prognostics, Inc.

FIG. 1 : Preterm Birth and PROM Testing Market: Research Methodology
FIG. 2 : Preterm Birth and PROM Testing: Market Segmentation
FIG. 3 : Global Preterm Birth and PROM Testing Market, by Test Type, 2017 (US$ Mn)
FIG. 4 : Global Preterm Birth and PROM Testing Market, by Geography, 2017 (US$ Mn)
FIG. 5 : Attractive Investment Proposition: by Geography, 2017
FIG. 6 : Competitive Analysis: Global Preterm Birth and PROM Testing Market, by Key Players, 2017
FIG. 7 : Global Pelvic Exam Market for Preterm Birth and PROM Testing, 2016 – 2026 (US$ Mn)
FIG. 8 : Global Ferning Test Market for Preterm Birth and PROM Testing, 2016 – 2026 (US$ Mn)
FIG. 9 : Global Nitrazine Test Market for Preterm Birth and PROM Testing, 2016 – 2026 (US$ Mn)
FIG. 10 : Global Pooling Test Market for Preterm Birth and PROM Testing, 2016 – 2026 (US$ Mn)
FIG. 11 : Global Ultrasound Test Market for Preterm Birth and PROM Testing, 2016 – 2026 (US$ Mn)
FIG. 12 : Global Uterine Monitoring Test Market for Preterm Birth and PROM Testing, 2016 – 2026 (US$ Mn)
FIG. 13 : Global Biomarkers Test Market for Preterm Birth and PROM Testing, 2016 – 2026 (US$ Mn)
FIG. 14 : U.S. Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 15 : Canada Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 16 : U.K. Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 17 : Germany Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 18 : Rest of Europe Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 19 : China Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 20 : Japan Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 21 : Rest of Asia Pacific Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 22 : Brazil Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 23 : Mexico Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 24 : Rest of Latin America Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 25 : GCC Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)
FIG. 26 : Rest of Middle East and Africa Preterm Birth and PROM Testing Market, 2016 – 2026 (US$ Mn)

TABLE 1 : Global Preterm Birth and PROM Testing Market Portraiture
TABLE 2 : Global Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 3 : Global Preterm Birth and PROM Testing Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 4 : North America Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 5 : North America Preterm Birth and PROM Testing Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 6 : Europe Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 7 : Europe Preterm Birth and PROM Testing Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 8 : Asia Pacific Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 9 : Asia Pacific Preterm Birth and PROM Testing Market, by Country/Region, 2015 – 2025 (US$ Mn)
TABLE 10 : Latin America Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 11 : Latin America Preterm Birth and PROM Testing Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 : Middle East and Africa Preterm Birth and PROM Testing Market, by Test Type, 2016 – 2026 (US$ Mn)
TABLE 13 : Middle East and Africa Preterm Birth and PROM Testing Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 14 : Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 15 : Biosynex: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 16 : Clinical Innovations, LLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17 : CooperSurgical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18 : Hologic, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19 : IQ Products: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20 : Medixbiochemica: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 : NX Prenatal, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 : Qiagen N.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 : Sera Prognostics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Our Clients